Company Search:
Advanced Search
Sponsored Links
Siegfried Holding AG Company Snapshot
Siegfried Holding AG operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other pharmaceutical manufacturers in Europe: Diasorin S.P.A. of Italy (2016 sales of 569.31 million Euro [US$697.69 million] ), Boiron SA of France (614.49 million Euro [US$753.05 million] of which 51% was Non-Proprietary Homeopathic Medicines), and Biotest AG which is based in Germany (553.10 million Euro [US$677.82 million] of which 63% was Therapy).

Sales Analysis. Siegfried Holding AG reported sales of 717.73 million Swiss Francs (US$745.30 million) for the year ending December of 2016. This represents an increase of 49.3% versus 2015, when the company's sales were 480.57 million Swiss Francs. Sales of Drug Substances saw an increase of 67.4% in 2016, from 333.20 million Swiss Francs to 557.90 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Siegfried Holding AG
  Stock Performance Chart for Siegfried Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 326.00
(Figures in Swiss Francs)
1 Week 0.8%   13 Weeks 5.8%  
4 Weeks 1.2%   52 Weeks 48.5%  
Siegfried Holding AG Key Data:
  Ticker: SFZN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 717,729,000
(Year Ending Jan 2017).
Employees: 2,315
  Currency: Swiss Francs Market Cap: 1,279,303,544
  Fiscal Yr Ends: December Shares Outstanding: 3,924,244
  Share Type: Namenaktie Closely Held Shares: 250,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.